Related Experiment Videos
[Side effects and toxicity of immunosuppressive agents]
1Unita' Operativa di Nefrologia, Dialisi e Trapianto Renale, Ospedale di Careggi, Firenze. salvadorim@ao-careggi.toscana.it
Summary
This review examines non-therapeutic toxicity of immunosuppressive drugs in renal transplantation. Newer drugs like Sirolimus show promise for reduced side effects compared to calcineurin inhibitors and steroids.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Immunosuppressive drugs are crucial for renal transplantation success.
- Current agents have significant non-therapeutic toxicities affecting patient outcomes.
- Understanding these side effects is vital for treatment planning.
Purpose of the Study:
- To review the non-therapeutic toxicities of current immunosuppressive drugs used in renal transplantation.
- To compare the side effect profiles of different drug classes.
- To highlight the need for novel immunosuppressants with improved safety.
Main Methods:
- Literature review of non-therapeutic side effects.
- Analysis of toxicity profiles of major immunosuppressive drug classes.
- Examination of emerging drug trial data.
Main Results:
- Calcineurin inhibitors (CNIs) commonly cause nephrotoxicity, cardiotoxicity, and post-transplant diabetes mellitus (PTDM).
- Steroids exhibit significant adverse effects on bone and cardiovascular health.
- Sirolimus demonstrates a potentially less severe side effect profile in preliminary studies.
Conclusions:
- Careful selection of immunosuppressants is necessary to balance efficacy and minimize non-therapeutic toxicity.
- Ongoing research aims to develop safer immunosuppressive agents for renal transplant recipients.
- Sirolimus warrants further investigation for its favorable toxicity profile.